Immunic (IMUX) Non Operating Income (2013 - 2026)
Immunic (IMUX) reported Non Operating Income of $647000.0 for Q1 2026, down 52.14% on a YoY basis from $1.4 million in Q1 2025, and down 83.93% sequentially from $4.0 million in Q4 2025.
Immunic (IMUX) Non Operating Income (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Non Operating Income data on file, last reported at $647000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 52.14% year-over-year to $647000.0; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 16.33% YoY), and the FY2025 full-year result was $6.1 million, up 346.68% from the prior year.
- Non Operating Income fell to $647000.0 in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.0 million in Q4 2025 to a low of -$5.7 million in Q1 2024.
- A 5-year average of $525882.4 and a median of $801000.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income slumped 388.18% in 2024 and jumped 783.11% in 2025, its largest moves.
- Tracing IMUX's Non Operating Income over 5 years: stood at $853000.0 in 2022, then surged by 112.08% to $1.8 million in 2023, then tumbled by 74.79% to $456000.0 in 2024, then soared by 783.11% to $4.0 million in 2025, then plunged by 83.93% to $647000.0 in 2026.
- Business Quant data shows IMUX's Non Operating Income at $647000.0 in Q1 2026, $4.0 million in Q4 2025, and $414000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | 647,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 647,000.00 |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 414,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | -5.70 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 801,000.00 |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 853,000.00 |
| Sep 30, 2022 | -1.11 Mn |
| Jun 30, 2022 | -1.29 Mn |
| Mar 31, 2022 | 627,000.00 |
| Dec 31, 2021 | 536,000.00 |
| Sep 30, 2021 | -905,000.00 |
| Jun 30, 2021 | 1.24 Mn |